Poop pills may stop brain fog in liver patients
NCT ID NCT07454408
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a fecal microbiota transplant (FMT) from healthy donors can prevent severe confusion (hepatic encephalopathy) in 40 patients who still get episodes despite standard drugs after a liver shunt procedure (TIPS). Participants receive either FMT or a placebo, and researchers track safety, recurrence rates, and quality of life. The goal is to find a new option for those not helped by current treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FECAL MICROBIOTA TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xi'an International Medical Center Hospital
Xi’an, Shanxi, 710100, China
Contact Phone: •••-•••-•••• Email: •••••@•••••